Merck Buys Peloton Therapeutics For $1.05B Ahead Of IPO
By Adam Rhodes ( May 21, 2019, 12:52 PM EDT) -- Merck said Tuesday it has agreed to snap up Peloton Therapeutics in a deal steered by Covington & Burling and Wilson Sonsini that could be worth a total of $2.2 billion — the day before the privately held biopharmaceutical company was set to price its initial public offering....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.